@AmerLabOSU

Amal Amer MD PhD | Dept of MI&I OSUCOM | autophagy, inflammasomes & immune responses in Alzheimer's disease, COVID-19, & Legionella infection 🧠🦠🔬👩🏽‍🔬

medicine.osu.edu/find-faculty/non-clinical/microbial-infection-and-immunity/amal-amer
Joined September 2020
  • Tweets221
  • Following345
  • Followers326
12Media
Amer Lab retweeted
JCI insight
@JCI_insightOct 5
A finding in mice suggests a new target for severe #COVID19 capable of dampening harmful inflammation while enhancing antiviral immunity: doi.org/10.1172/jci.insight.… Mostafa M. Eltobgy @mostafaeltobgy2, Amal Amer @AmerLabOSU @OSUWexMed @OhioStateMed @OhioStateNeuro discover that blocking the inflammatory protein caspase-11 restores virus-fighting T cells and improves viral clearance in mice. The figure: CASP11 deficiency in hematopoietic immune cells enhances survival, reduces inflammation, and promotes T cell response after SARS-CoV-2 infection. #SARSCoV2
4
8
1,020
Excited to share our new study in @JCI_insight . We show that Caspase-11–driven hyperinflammation impairs antiviral CD8⁺ T cell immunity and delays viral clearance during severe SARS-CoV-2 infection. insight.jci.org/articles/vie…
2
7
402
Exciting news! The #OSUCOM Medical Scientist Training Program (MSTP) has been renewed for 5 years, giving medical and scientific training for 20 predoctoral students. Learn more 🩺 medicine.osu.edu/news/mstp-t…

MSTP T32 grant renewal supports five years of medical and scientific training | Ohio State College...

Here is some info from Ohio State – improving lives through excellence in research, education and patient care.

medicine.osu.edu
6
19
812
Our work is finally out in @JCI_insight ! Using immunopeptidomics, bioinformatics & T-cell assays we discovered novel CD4⁺ T cell-recognized B. pertussis antigens that reduce airway colonization. A long journey and a fantastic collaborative effort! insight.jci.org/articles/vie……
2
3
368
Six #OSUCOM faculty, Drs. Amal Amer, Beth Kozel, Kristy Townsend, Rebecca Wallihan, Amy Kerger and Courtney Collins, have been named to prestigious leadership fellowships in academic medicine. 👏 medicine.osu.edu/news/six-fe…

Six female faculty members accepted to prestigious leadership and healthcare fellowships | Ohio...

Here is some info from Ohio State – improving lives through excellence in research, education and patient care.

medicine.osu.edu
3
2
15
2,089
We're excited to announce that Dana M. McTigue, PhD, has been named Vice Dean for Research at #OSUCOM, pending approval by the Board of Trustees. Dr. McTigue has served as the college’s Associate Dean for Foundational Research since 2021. Congratulations Dr. McTigue! ♥️
4
7
1
25
1,383
17
188
6
735
14,356
Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection @biorxivpreprint @mostafaeltobgy2 biorxiv.org/content/10.1101/…
3
10
1,008
We are proud to be ranked on the @USNews "Best Hospitals" list in recognition of our dedication to providing safe, compassionate, leading-edge medical care. We're honored to be named the top hospital in central Ohio with 9 nationally ranked specialties.wexnermedical.osu.edu/mediar…

Ohio State Wexner Medical Center ranked No. 1 in Columbus by U.S. News & World Report

.@USNews has ranked @OSUWexMed among the top healthcare institutions nationwide for the 33rd year in a row.

wexnermedical.osu.edu
1
6
2
28
10,191
Axios: 'The cure for long COVID may come from Ohio State' 'Ohio State researchers are working toward a cure for long COVID, supported by the school's largest grant ever received for an infectious diseases study' axios.com/local/columbus/202…

The cure for long COVID may come from Ohio State

OSU researchers are using a $15 million grant to find it.

axios.com
21
244
15
1,251
41,365
At Ohio State University, researchers found that SARS-CoV-2-infected mice showed long COVID-like brain fog weeks after infection. Using AI and automated behavioral tests, they linked these deficits to gene changes also seen in human patients. biorxiv.org/content/10.1101/…

AI-based decoding of long covid cognitive impairments in mice using automated behavioral system and...

Long COVID (LC) following SARS-CoV-2 infection affects millions of individuals world-wide and manifests with a variety of symptoms including cognitive dysfunction also known as “brain fog”. This is...

biorxiv.org
1
37
101
3,583
Announcing, one of a unique conference. #CellDeath, #Innateimmunity, and #Autophagy. Top speakers, top Science. website -open soon- Please retweet. @EMBO @India_Alliance @ccmb_csir @CSIR_IND @jkagan1 @dixitvishva @vpderetic @v_hornung @ThiruKanneganti @ClareBryant13 @iDikic2
62
4
177
17,302
NPR: 'A push to understand long COVID' 'The National Institutes of Health announced a $300 million investment to research treatments for long COVID' 'In the US, there are an estimated 17M adults with LC. Many unable to work or care for their families' npr.org/2024/12/23/g-s1-3971…

Biden commutes 37 federal death row sentences. And, a push to understand long COVID

President Biden commuted 37 of the 40 men on federal death row to life without parole this morning. Here are the factors that drove his decision. And, a push to better understand long COVID.

npr.org
4
36
6
190
14,283
Discover The JI’s Brief Reviews - These insightful articles cover emerging and evolving areas in #immunology, while also providing a balanced view of the current #research. Explore the series now: ow.ly/5HXq50U0BFL. #ReadTheJI
2
3
998
95
1,097
55
7,819
293,645
Please share this post! 🤓
The Journal of Immunology@J_Immunol18 Sep 2024
Are you a grad student or #postdoc looking to improve your peer review skills? This FREE webinar is for you! Learn from the experts and register today: ow.ly/X8lw50ToaYc. #ScienceCareers #Immunology
A graphic advertising a webinar titled 'How to Be the Reviewer You Want to Have,' taking place on September 23, 2024, from 3:00 to 4:00 PM EDT. The speaker is Gail A. Bishop, Ph.D., Editor-in-Chief of The Journal of Immunology.

ALT A graphic advertising a webinar titled 'How to Be the Reviewer You Want to Have,' taking place on September 23, 2024, from 3:00 to 4:00 PM EDT. The speaker is Gail A. Bishop, Ph.D., Editor-in-Chief of The Journal of Immunology.

1
504
Amazing night talking about life and science with our speaker @TheColonnaLab of the joint campus-wide #immunology seminar series, along with @EugeneOltz, @AmerLabOSU and Prosper Boyaka!! @OhioStatePIIO @OSUWexMed @OhioStateMed
3
33
2,105
'..and better understand the long-term consequences of the virus. They recently received a $15 million federal grant from the NIH to find solutions to long COVID. This Tuesday, we will speak to the project lead about their progress thus far.'
1
1
8
529
Dr. Amer, Ohio State Univ. on IPM today, "I got COVID three times...after the second time, I suffered from brain fog..it was the most horiftying experience of my life. This was very scary..my job depends on my brain. All of a sudden I couldn't even type...it was really shocking."
Billy Hanlon@bhanlon1527 Aug 2024
'As COVID-19 surges in NEO, public health experts discuss new vaccine, long COVID research' '..one phenomenon continues to remain a mystery: long COVID' 'At Ohio State University, a team of researchers are working to develop effective treatments..' ideastream.org/show/sound-of…

As COVID-19 surges in NEO, public health experts discuss new vaccine, long COVID research

The Cuyahoga County medical director and a Cleveland Clinic physician discuss the new COVID-19 vaccine and how to prepare for other fall viruses.

ideastream.org
8
138
11
433
25,474
A 2022 study @OSUWexMed suggests that blocking one molecule could protect against severe illness with the SARS-CoV-2 virus has now led to a $15M grant from @NIH to find ways to combat the effects of long COVID. Amal Amer, MD, PhD is quoted. @OhioStateMed bit.ly/4d2FhVx

Finding a solution for long COVID, one cell type at a time

A 2022 study suggesting that blocking a single molecule could protect against severe illness in COVID-19 has led to a $15 million federal grant supporting a comprehensive effort to learn more – with...

news.osu.edu
6
1
13
927
Load more